Simple and Practical Mental Health

The BEST resource for mental health clinicians

  • REVIEWS
  • MENUS
  • RESOURCES
    • Side effect handouts
    • Patient handouts: Main page
    • How to find treatment resources
    • Rating scales and questionnaires for mental health clinicians
    • BEST books
    • BEST apps/ websites
  • NEWS
  • QUESTIONS?
  • DAILY EMAILS
  • FAQ
  • LOG IN
  • JOIN

Flibanserin (Addyi®): Systematic list of references

Here are some key references about flibanserin as of April 2019:

Meta-analyses

Jaspers L, Feys F, Bramer WM, Franco OH, Leusink P, Laan ET. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016 Apr 1;176(4):453-62. PubMed PMID: 26927498.


Clinical trials

Clayton AH, Croft HA, Yuan J, Brown L, Kissling R. Safety of Flibanserin in Women Treated With Antidepressants: A Randomized, Placebo-Controlled Study. J Sex Med. 2018 Jan;15(1):43-51. doi: 10.1016/j.jsxm.2017.11.005. PubMed PMID: 29289374. NCT01040208.

Derogatis LR, Komer L, Katz M, Moreau M, Kimura T, Garcia M Jr, Wunderlich G, Pyke R; VIOLET Trial Investigators. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study. J Sex Med. 2012 Apr;9(4):1074-85. PubMed PMID: 22248038.

Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial. J Sex Med. 2011 Nov;8(11):3160-72. PubMed PMID: 21933348.

Jayne C, Simon JA, Taylor LV, Kimura T, Lesko LM; SUNFLOWER study investigators. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder. J Sex Med. 2012 Dec;9(12):3180-8. PubMed PMID: 23057791.

Katz M, DeRogatis LR, Ackerman R, Hedges P, Lesko L, Garcia M Jr, Sand M; BEGONIA trial investigators. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med. 2013 Jul;10(7):1807-15. PubMed PMID: 23672269.

Portman DJ, Brown L, Yuan J, Kissling R, Kingsberg SA. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study. J Sex Med. 2017 Jun;14(6):834-842. doi: 10.1016/j.jsxm.2017.03.258. PubMed PMID: 28583342.

Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M Jr, Sand M. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Menopause. 2014 Jun;21(6):633-40. PubMed PMID: 24281236.

Thorp J, Simon J, Dattani D, Taylor L, Kimura T, Garcia M Jr, Lesko L, Pyke R; DAISY trial investigators. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med. 2012 Mar;9(3):793-804. PubMed PMID: 22239862.


Unpublished clinical trials

Alternate Dose Study (NCT00360243)

EU Study (NCT00491829)

Terminated Study (NCT01057901)


Related Pages

Flibanserin (Addyi)

Flibanserin (Addyi®) in postmenopausal women

Flibanserin (Addyi®): Basic information

YOU Ask the Expert: How to identify, assess, and manage medication-induced sexual dysfunction (Interview with Anita Clayton, MD)

Transdermal testosterone for hypoactive sexual desire disorder in postmenopausal women

An introduction to the Changes in Sexual Functioning Questionnaire (CSFQ)

How to administer, score, and interpret the Changes in Sexual Functioning Questionnaire (CSFQ)

Arizona Sexual Experiences Scale (ASEX)


This page was last updated on April 13, 2019


Copyright 2016 to 2019, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.

Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other lay persons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.

Share this:

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email

Leave a Reply:Cancel reply

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter

Copyright 2016 to 2025: Simple and Practical Medical Education, LLC. All rights reserved.